| __timestamp | Halozyme Therapeutics, Inc. | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 52602000 | 2614539000 |
| Thursday, January 1, 2015 | 105812000 | 3711019000 |
| Friday, January 1, 2016 | 113485000 | 4560733000 |
| Sunday, January 1, 2017 | 285461000 | 5475166000 |
| Monday, January 1, 2018 | 141726000 | 6276700000 |
| Tuesday, January 1, 2019 | 150446000 | 7081200000 |
| Wednesday, January 1, 2020 | 224227000 | 7377200000 |
| Friday, January 1, 2021 | 361897000 | 13634200000 |
| Saturday, January 1, 2022 | 520812000 | 10612500000 |
| Sunday, January 1, 2023 | 636892000 | 11301400000 |
| Monday, January 1, 2024 | 855907000 | 12231500000 |
Unleashing insights
In the dynamic world of biotechnology, financial performance is a key indicator of a company's success and innovation. Over the past decade, Regeneron Pharmaceuticals, Inc. and Halozyme Therapeutics, Inc. have showcased contrasting trajectories in their gross profit trends. From 2014 to 2023, Regeneron has consistently outperformed, with its gross profit surging by approximately 332%, peaking in 2021. This growth reflects Regeneron's robust pipeline and strategic market positioning. In contrast, Halozyme's gross profit, while more modest, has seen a steady increase of around 1,110% over the same period, highlighting its resilience and potential in niche markets. The year 2021 marked a significant milestone for both companies, with Regeneron achieving its highest gross profit, while Halozyme continued its upward trend. These insights underscore the diverse strategies and market dynamics shaping the biotech industry today.
Gross Profit Trends Compared: Johnson & Johnson vs Halozyme Therapeutics, Inc.
Key Insights on Gross Profit: Gilead Sciences, Inc. vs Regeneron Pharmaceuticals, Inc.
Key Insights on Gross Profit: Gilead Sciences, Inc. vs Halozyme Therapeutics, Inc.
Vertex Pharmaceuticals Incorporated vs Regeneron Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: Regeneron Pharmaceuticals, Inc. vs Incyte Corporation
Regeneron Pharmaceuticals, Inc. and Jazz Pharmaceuticals plc: A Detailed Gross Profit Analysis
Regeneron Pharmaceuticals, Inc. vs Amneal Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Who Generates Higher Gross Profit? Regeneron Pharmaceuticals, Inc. or Amphastar Pharmaceuticals, Inc.
Gross Profit Trends Compared: United Therapeutics Corporation vs Halozyme Therapeutics, Inc.
Gross Profit Analysis: Comparing Exelixis, Inc. and Halozyme Therapeutics, Inc.
Gross Profit Analysis: Comparing Halozyme Therapeutics, Inc. and Grifols, S.A.
Halozyme Therapeutics, Inc. vs Vericel Corporation: A Gross Profit Performance Breakdown